CCT, µm | CV, % | CD, cells/mm2 | Hexa, % | ||
Lifetime alcohol | Spearman’s correlation coefficient (ρ) | −0.035 | −0.037 | 0.002 | 0.037 |
P value | 0.668 | 0.651 | 0.984 | 0.646 | |
Number of patients | 155 | 155 | 155 | 155 | |
Years of drinking | Spearman’s correlation coefficient (ρ) | −0.033 | −0.143 | −0.008 | 0.191 |
P value | 0.678 | 0.075 | 0.917 | 0.016* | |
Number of patients | 157 | 157 | 157 | 157 | |
GGT | Spearman’s correlation coefficient (ρ) | −0.023 | −0.143 | −0.107 | 0.185 |
P value | 0.773 | 0.071 | 0.178 | 0.019* | |
Number of patients | 160 | 160 | 160 | 160 | |
ALT | Spearman’s correlation coefficient (ρ) | 0.051 | 0.024 | −0.122 | 0.042 |
P value | 0.519 | 0.768 | 0.124 | 0.600 | |
Number of patients | 160 | 160 | 160 | 160 | |
AST | Spearman’s correlation coefficient (ρ) | 0.049 | −0.045 | −0.145 | 0.060 |
P value | 0.539 | 0.575 | 0.067 | 0.452 | |
Number of patients | 160 | 160 | 160 | 160 | |
MCV | Spearman’s correlation coefficient (ρ) | 0.040 | 0.138 | 0.066 | −0.094 |
P value | 0.617 | 0.082 | 0.407 | 0.239 | |
Number of patients | 159 | 159 | 159 | 159 | |
AUDIT | Spearman’s correlation coefficient (ρ) | 0.057 | 0.043 | −0.002 | −0.062 |
P value | 0.475 | 0.593 | 0.985 | 0.438 | |
Number of patients | 160 | 160 | 160 | 160 | |
ASI | Spearman’s correlation coefficient (ρ) | −0.085 | 0.070 | 0.015 | −0.118 |
P value | 0.285 | 0.384 | 0.855 | 0.137 | |
Number of patients | 159 | 159 | 159 | 159 |
↵*Significant (P<0.05).
ADS, alcohol dependence syndrome; ALT, alanine amino-transferase; ASI, Addiction Severity Index; AST, aspartate amino-transferase; AUDIT, Alcohol Use Disorder Identification Test; CCT, central corneal thickness; CD, cell density; CV, coefficient of variation; GGT, gamma glutamyl transferase; MCV, mean corpuscular volume.